90 related articles for article (PubMed ID: 1903260)
21. Alkaline treatment after X-Gal staining reaction for Escherichia coli beta-galactosidase enhances sensitivity.
Tanahashi H; Tabira T
Anal Biochem; 2000 Mar; 279(1):122-3. PubMed ID: 10683242
[No Abstract] [Full Text] [Related]
22. Reliable transient promoter assay using fluorescein-di-beta-D-galactopyranoside substrate.
Ikenaka K; Fujino I; Morita N; Iwasaki Y; Miura M; Kagawa T; Nakahira K; Mikoshiba K
DNA Cell Biol; 1990 May; 9(4):279-86. PubMed ID: 1693513
[TBL] [Abstract][Full Text] [Related]
23. A chemiluminescent assay for quantitation of beta-galactosidase in the femtogram range: application to quantitation of beta-galactosidase in lacZ-transfected cells.
Jain VK; Magrath IT
Anal Biochem; 1991 Nov; 199(1):119-24. PubMed ID: 1807155
[TBL] [Abstract][Full Text] [Related]
24. [Using reporter gene to compare infection efficiency of HIV-1 pseudovirus to suspended and adherent cells].
Su Y; Su L; Yin T; Zhang B
Wei Sheng Wu Xue Bao; 2012 Jul; 52(7):921-6. PubMed ID: 23115978
[TBL] [Abstract][Full Text] [Related]
25. Stable indicator cell lines exhibiting HIV-1 tat function.
Bacheler LT; Strehl LL; Neubauer RH; Petteway SR; Ferguson BQ
AIDS Res Hum Retroviruses; 1989 Jun; 5(3):275-8. PubMed ID: 2543431
[TBL] [Abstract][Full Text] [Related]
26. Inducible gene expression of the human immunodeficiency virus LTR in a replication-incompetent herpes simplex virus vector.
Warden MP; Weir JP
Virology; 1996 Dec; 226(1):127-31. PubMed ID: 8941330
[TBL] [Abstract][Full Text] [Related]
27. Vaccinia virus vectors utilizing the beta-galactosidase assay for rapid selection of recombinant viruses and measurement of gene expression.
Panicali D; Grzelecki A; Huang C
Gene; 1986; 47(2-3):193-9. PubMed ID: 3104141
[TBL] [Abstract][Full Text] [Related]
28. [Use of U3 promotor from the LTR region of bovine leukemia virus for expressing genes for antiviral antisense RNAs in cell cultures].
Borisenko AS; Shaiakhmetov DM; Gerzilova AG; Tikhonenko TI
Mol Gen Mikrobiol Virusol; 1994; (3):16-20. PubMed ID: 8065378
[TBL] [Abstract][Full Text] [Related]
29. Human immunodeficiency virus type 1 (HIV-1) provirus expression and LTR transcription are repressed in NEF-expressing cell lines.
Maitra RK; Ahmad N; Holland SM; Venkatesan S
Virology; 1991 Jun; 182(2):522-33. PubMed ID: 2024488
[TBL] [Abstract][Full Text] [Related]
30. lacZ transgenic rats tolerant for beta-galactosidase: recipients for gene transfer studies using lacZ as a reporter gene.
Ménoret S; Aubert D; Tesson L; Braudeau C; Pichard V; Ferry N; Anegon I
Hum Gene Ther; 2002 Jul; 13(11):1383-90. PubMed ID: 12162820
[TBL] [Abstract][Full Text] [Related]
31. Genetic manipulation of African swine fever virus: construction of recombinant viruses expressing the beta-galactosidase gene.
Rodríguez JM; Almazán F; Viñuela E; Rodriguez JF
Virology; 1992 May; 188(1):67-76. PubMed ID: 1566585
[TBL] [Abstract][Full Text] [Related]
32. A sensitive and versatile bioluminescence bioassay for HIV type 1 based on adenoviral vectors.
Axelrod JH; Honigman A
AIDS Res Hum Retroviruses; 1999 May; 15(8):759-67. PubMed ID: 10357471
[TBL] [Abstract][Full Text] [Related]
33. Establishment of a simple and rapid method to screen for strong promoters in Bacillus subtilis.
Phan TT; Nguyen HD; Schumann W
Protein Expr Purif; 2010 Jun; 71(2):174-8. PubMed ID: 19963063
[TBL] [Abstract][Full Text] [Related]
34. Improved method for coliphage detection based on beta-galactosidase induction.
Ijzerman MM; Hagedorn C
J Virol Methods; 1992 Oct; 40(1):31-6. PubMed ID: 1341886
[TBL] [Abstract][Full Text] [Related]
35. Myb protein binds to human immunodeficiency virus 1 long terminal repeat (LTR) sequences and transactivates LTR-mediated transcription.
Dasgupta P; Saikumar P; Reddy CD; Reddy EP
Proc Natl Acad Sci U S A; 1990 Oct; 87(20):8090-4. PubMed ID: 2236022
[TBL] [Abstract][Full Text] [Related]
36. High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B.
Negrini M; Rimessi P; Sabbioni S; Caputo A; Balboni PG; Gualandri R; Manservigi R; Grossi MP; Barbanti-Brodano G
Biotechniques; 1991 Mar; 10(3):344-53. PubMed ID: 1829615
[TBL] [Abstract][Full Text] [Related]
37. Comments on Methods to Suppress Endogenous β-Galactosidase Activity in Mouse Tissues Expressing the LacZ Reporter Gene.
Merkwitz C; Blaschuk O; Schulz A; Ricken AM
J Histochem Cytochem; 2016 Oct; 64(10):579-86. PubMed ID: 27555495
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the response to T-cell activation by integrated HIV-1 and HTLV-1 LTR-lacZ vectors.
Copeland KF; Hendrikx PJ; Haaksma AG; Fiering S; Van Lier R; Goudsmit J; Heeney JL
Virology; 1995 Jun; 209(2):633-6. PubMed ID: 7778294
[TBL] [Abstract][Full Text] [Related]
39. Identification of human cytomegalovirus target sequences in the human immunodeficiency virus long terminal repeat. Potential role of IE2-86 binding to sequences between -120 and -20 in promoter transactivation.
Yurochko AD; Huong SM; Huang ES
J Hum Virol; 1999; 2(2):81-90. PubMed ID: 10225210
[TBL] [Abstract][Full Text] [Related]
40. New multifunctional Escherichia coli-Streptomyces shuttle vectors allowing blue-white screening on XGal plates.
Wehmeier UF
Gene; 1995 Nov; 165(1):149-50. PubMed ID: 7489909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
